G Corvi

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

Double‐blind study of the analgesic effect of indoprofen (K 4277)

L. M. Fuccella, Franco Conti, G Corvi et al. · Clinical Pharmacology & Therapeutics · 1975 · 28 citations

Pharmacokinetic, bioavailability and pharmacodynamic study of indobufen (K 3920), an inhibitor of platelet aggregation, after a single dose in man

L. M. Fuccella, G Corvi, E. Moro et al. · European Journal of Clinical Pharmacology · 1979 · 27 citations

Thrombopoiesis, Thrombosis, Blood Platelet +9

Indobufen (K 3920), a new inhibitor of platelet aggregation: Effect of food on bioavailability, pharmacokinetic and pharmacodynamic study during repeated oral administration to man

V. Tamassia, G Corvi, L. M. Fuccella et al. · European Journal of Clinical Pharmacology · 1979 · 23 citations

Thrombopoiesis, Molecular Pharmacology, Thrombosis +9

Gastro-Intestinal Blood Loss during Administration of Indoprofen, Aspirin and Ibuprofen

G. Bianchi Porro, G Corvi, L. M. Fuccella et al. · Journal of International Medical Research · 1977 · 20 citations